Prime Medicine CEO eyes CAR-T therapy for autoimmune diseases.
TL;DR
Prime Medicine is considering developing cell therapies for autoimmune diseases and may seek a partner for cancer cell therapies. The biotech would join a growing list of groups creating CAR-T therapies for autoimmune conditions like lupus, which were first developed for cancer and have been transformative for patients who can access them.
Want the full story? Read the original reporting
Read on Endpoints News